ArticlePlant cell reports2026
The transcription factor AtANAC070 enhances zinc tolerance by promoting AtMTP1 expression in Arabidopsis thaliana.
Article in Plant cell reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
key messageThe NAC transcription factor AtANAC070 functions in zinc tolerance by directly activating AtMTP1 transcription to promote vacuolar zinc sequestration and homeostasis in A. thaliana. Zinc (Zn) is an essential micronutrient for plant growth, but it becomes toxic when present in excess. An initial screen of Arabidopsis thaliana T-DNA insertion mutants suggested a positive role of AtANAC070 in tolerance to excess Zn. AtANAC070 expression was induced under excess Zn, and loss of function of AtANAC070 led to increased Zn sensitivity and higher Zn accumulation. Conversely, AtANAC070 overexpression enhanced Zn tolerance and reduced Zn accumulation. Yeast one-hybrid assays identified Metal Tolerance Protein 1 (AtMTP1), which encodes a key transporter mediating vacuolar sequestration of excess Zn, as a downstream target of AtANAC070. Dual-luciferase reporter and real-time quantitative PCR (RT-qPCR) assays confirmed that AtANAC070 directly binds to the AtMTP1 promoter to activate its expression. The atmtp1 mutant accumulated more Zn than the WT and was more sensitive to excess Zn, whereas AtMTP1-overexpressing lines showed the opposite phenotype. The atanac070 atmtp1 double mutant displayed Zn sensitivity comparable to that of atmtp1 mutant, while AtMTP1 overexpression in the atanac070 background reduced Zn accumulation and restored Zn tolerance. These results indicate that AtANAC070 contributes to Zn homeostasis under excess Zn by promoting AtMTP1 expression.
Indexed as
Identifiers
42566041What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.